Please login to read the full article.
Scrip Regulatory Affairs
India consults on compensating patients injured in drug, device trials
30 November 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Big Pharma plans for compensating Indian trial deaths highlights need for guidelines
- US regulators invite comments on guidance on exculpatory language in informed consent
- US IOM analysis finds little evidence of vaccine harm, debunks autism link
- US FDA invites feedback on IOM advice to scrap 510(k) process
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
